Glen Taksler, PhD
Cleveland Clinic Main Campus
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.View All Plans
About Glen Taksler, PhD
Glen Taksler is Associate Professor of Medicine at Cleveland Clinic Lerner College of Medicine; Staff at Cleveland Clinic Community Care and Cleveland Clinic's Department of Quantitative Health Sciences; and Faculty at the Center for Health Care Research and Policy, Population Health Research Institute at Case Western Reserve University at The MetroHealth System. His research focuses on disease prevention, with particular attention to improving the understanding of factors that improve long-term health. He has developed methods to individualize preventive health care guidelines based on patient-specific risk factors and prioritize preventive services based on their potential to improve longevity. Currently, Dr. Taksler is Principal Investigator of a study funded by the National Institutes of Health (National Institute on Aging) to help middle-aged adults make an informed decision about the primary preventive services that are most likely to promote a longer, healthier life. He also founded and leads an electronic health records-based registry of more than 800,000 primary care patients. Dr. Taksler’s other work includes analyzing years of life lost to major causes of death, implications of false-positives in cancer screening, communitywide (herd immunity) benefits of influenza vaccination and explaining racial disparities in vitamin D deficiency and prostate cancer mortality. His methods include decision analytic and predictive risk modeling, economic analysis and observational study designs using large datasets.
In 2019, Dr. Taksler received the Award for Excellence in Clinical Investigation, awarded to one outstanding junior faculty member in the Midwest by the Society of General Internal Medicine Midwest Region. Previously, he received 2 national awards for best junior faculty research, the Most Outstanding Paper by a Young Investigator Award by the Society for Medical Decision Making and the Milton W. Hamolsky Award for Most Outstanding Junior Faculty Abstract by the Society of General Internal Medicine.
Dr. Taksler has published in high-impact journals such as Annals of Internal Medicine, American Journal of Public Health, American Journal of Preventive Medicine, JAMA Oncology, Cancer and Clinical Infectious Diseases. He has served as a reviewer for more than a dozen academic journals.
Dr. Taksler holds a BA in Economics and Mathematical Sciences from Johns Hopkins University, an AM and PhD in Economics from Harvard University, and a postdoctoral fellowship in Population Health and Medicine from New York University School of Medicine. His research has been funded by the National Institute on Aging, National Center for Advancing Translational Sciences, Clinical and Translational Science Collaborative of Cleveland and Dana-Farber Cancer Institute.
Education & Professional Highlights
Education & Fellowships
Fellowship - New York University School of Medicine
Population Health and Medicine
New York, NY USA
Medical Education - Harvard University
Cambridge, MA USA
Graduate School - Harvard University
Cambridge, MA USA
Undergraduate - Johns Hopkins University
Baltimore, MD USA
Awards & Honors
- Top-Ranked Abstracts, Society for Medical Decision Making, 2012
- Milton W. Hamolsky Award for Most Outstanding Junior Faculty Abstract, Society of General Internal Medicine, 2014
- Most Outstanding Paper by a Young Investigator Award, Society for Medical Decision Making, 2014
- Abstract of the Day, Society of General Internal Medicine, 40th Annual Meeting, 2017
- July Editor's Choice article, American Journal of Preventive Medicine, 2018
- Award for Excellence in Clinical Investigation, Society of General Internal Medicine Midwest Region, 2019
Research & Publications
See publications for Glen Taksler, PhD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/13/2022, Dr. Taksler has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.